Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering ·         Enables in vivo delivery of LEU011 harnessing the VivoCell PlatformTM London, UK and Chicago, ...

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

Biotechnology company Leucid Bio announced a strategic collaboration with Syenex, an open-source gene therapy platform firm.

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...

The ambient air on planes and in hospitals mostly contains harmless microbes typically associated with human skin, ...

Research led by Professor Philip C. Y. Chow and his PhD student Ms. Yumeng Song from the Department of Mechanical Engineering ...

Port offers a proprietary alternative to Spotify's popular devtool catalog Backstage, but with a valuable addition — it can ...

Several experts told me that Chinese companies are even with or slightly ahead of their American counterparts when it comes ...

Spot’s trajectory quickly diverted from inside a lab to under the limelight. Within months, the robot was strutting across ...

For years, the conversation about Huawei in the West has been about what the company cannot do. However, focusing solely on ...

The DOW FutureG program director will give an illuminating keynote address at the 2026 Defense R&D Summit, a GovCon industry ...

After Taiwanese prosecutors opened the national security inquiry into Mr. Lo late last month, TSMC filed a lawsuit against ...